| dc.contributor.advisor | Lankeit, Mareike Katharina | |
| dc.contributor.author | Niemann, Caroline | |
| dc.date.accessioned | 2016-11-28T07:09:41Z | |
| dc.date.available | 2016-12-15T23:50:06Z | |
| dc.date.issued | 2016-11-28 | |
| dc.identifier.uri | http://hdl.handle.net/11858/00-1735-0000-002B-7CBE-A | |
| dc.identifier.uri | http://dx.doi.org/10.53846/goediss-5995 | |
| dc.language.iso | deu | de |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject.ddc | 610 | de |
| dc.title | Angiopoietin-2 — ein neuer Biomarker bei Patienten mit akuter Lungenembolie | de |
| dc.type | doctoralThesis | de |
| dc.title.translated | Angiopoietin-2 — a novel biomarker in patients with pulmonary embolism | de |
| dc.contributor.referee | Lankeit, Mareike Katharina | |
| dc.date.examination | 2016-12-08 | |
| dc.description.abstracteng | Angiopoietin-2 (Ang-2), an antagonist ligand of the endothelial-specific Tie2 receptor, inhibits the stabilizing influence of the Tie2 activator Ang-1, thereby promoting vascular remodeling. Elevated levels of Ang-2 are associated with impaired hemodynamic parameters and poor prognosis in patients with idiopathic pulmonary hypertension. This thesis aimed to investigate the prognostic value of Ang-2 in patients with acute pulmonary embolism (PE). | de |
| dc.contributor.coReferee | Patschan, Daniel Prof. Dr. | |
| dc.subject.ger | Lungenembolie | de |
| dc.subject.ger | Angiopoietin-2 | de |
| dc.subject.ger | CTEPH | de |
| dc.subject.eng | pulmonary embolism | de |
| dc.subject.eng | Angiopoietin-2 | de |
| dc.subject.eng | CTEPH | de |
| dc.identifier.urn | urn:nbn:de:gbv:7-11858/00-1735-0000-002B-7CBE-A-4 | |
| dc.affiliation.institute | Medizinische Fakultät | de |
| dc.subject.gokfull | Kardiologie (PPN619875755) | de |
| dc.description.embargoed | 2016-12-15 | |
| dc.identifier.ppn | 87500265X | |